Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06899789
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:40.858194+00:00
Published At
2025-03-28T00:00:00+00:00
Record Updated At
2025-03-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Immune Checkpoint Inhibitors-induced Colitis", "Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney Adenocarcinoma", "Ileo-colitis", "Immune Mediated-colitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-28"
protocolSection.identificationModule.nctId
"NCT06899789"
protocolSection.identificationModule.officialTitle
"Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Immune Checkpoint Inhibitors-induced Colitis (protocolSection.conditionsModule.conditions)
  • Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Ileo-colitis (protocolSection.conditionsModule.conditions)
  • Immune Mediated-colitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.